{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > JAK/STAT > NifuroxazideCAS：965-52-6
Molecular Formula：C12H9N3O5
Molecular Weight：275.22
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Light yellow to yellow Solid
Qty：
Size：
| CAS | 965-52-6 |
| Name | Nifuroxazide |
| Molecular Formula | C12H9N3O5 |
| Molecular Weight | 275.22 |
| Solubility | Soluble in DMSO ≥5mg/mL;Soluble in Water/Ethanol < 1mg/mL |
| Purity | ≥98% |
| Appearance | Light yellow to yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 213-522-0 |
| MDL | MFCD00079482 |
| SMILES | O=C(N/N=C/C1=CC=C([N+]([O-])=O)O1)C2=CC=C(O)C=C2 |
| Target Point | STAT3 |
| Passage | JAK/STAT Signaling |
| Background | Nifuroxazide is a potent inhibitor of STAT3 with anticancer and antimetastatic activity. |
| Biological Activity | Nifuroxazide 是 STAT3 的有效抑制剂，且具有抗癌和抗转移活性。[1-2] |
| Data Literature Source | [1]. Nelson EA，et al. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. Blood. 2008 Dec 15;112(13):5095-102. [2]. Zhu Y，et al. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Sci Rep. 2016 Feb 2;6:20253. |
| Unit | Bottle |
| Specification | 100mg 500mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
